Contemporary short-term post-operative outcomes after resection of entero-pancreatic NETs: a population-based study
Meloche-Dumas L, Singh S, Law C, Chan WC, Ding A, Armah J, Hallet J. Eur J Surg Oncol. 2026; 52(7): 111877. Epub 2026 May 12.
Publications
Patient-reported symptom and urgent healthcare use in neuroendocrine tumors
Hallet J, Noel C, Sutradhar R, Duncan K, Law C, Singh S, Myrehaug S, Coburn N, Chan WC, Gombay A, Eskander A. Endocr Oncol. 2026; 6(1):e250050. Epub 2026 Jan 19.
Contemporary incidence and survival of lung neuroendocrine neoplasms
Hallet J, Rousseau M, Wakeam E, Myrehaug S, Meloche-Dumas L, Gombay A, Chan W, Singh S. JAMA Netw Open. 2025; 8(10):e2535125.
Early mortality in patients with cancer and COVID-19 infection treated with immunotherapy
Raphael J, Le B, Singh S, Blanchette P, Trudeau M, Lam M, Cheung M. BMC Cancer. 2025; 25(1):922.
Incidence and factors associated with heart disease in patients diagnosed with small bowel and broncho-pulmonary neuroendocrine tumors: a population-based analysis
Hallet J, Ahmed S, Singh S, Myrehaug S, Chan WC, Gombay A, Law C. Surg Oncol Insight. 2025; 2(1): 100115. Epub 2024 Dec 4.
The impact of marginalization on diffuse large B-cell lymphoma overall survival: a retrospective cohort study
Arya S, Mozessohn L, Gong I, Faught N, Liu N, Singh S, Chan K, Cheung MC. Leuk Lymphoma. 2024; Jan 24 [Epub ahead of print].
Indolent lymphoma care delivery and outcomes during the COVID-19 pandemic in Ontario, Canada
Gong IY, Prica A, Ante Z, Calzavara A, Krzyzanowska MK, Singh S, Suleman A, Cheung MC, Crump M. Br J Haematol. 2023; Oct 27 [Epub ahead of print].
Association between the COVID-19 pandemic and first cancer treatment modality: a population-based cohort study
Fu R, Sutradhar R, Li Q, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Dare A, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Finelli A, Louie AV, Look Hong NJ, Witterick IJ, Mahar A, Urbach DR, McIsaac DI, Enepekides D, Eskander A. CMAJ Open. 2023; 11(3):E426-33. Epub 2023 May 9.
Early survival for patients newly diagnosed with cancer during COVID-19 in Ontario, Canada: a population-based cohort study
Fu R, Sutradhar R, Li Q, Kalraj P, Dare A, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Louie AV, Mahar A, Urbach DR, McIsaac DI, Enepekides D, Gomez D, Look Hong NJ, Tinmouth J, Eskander A. Cancer Med. 2023; 12(10):11849-59. Epub 2023 Mar 31.
Timeliness and modality of treatment for new cancer diagnoses during the COVID-19 pandemic in Canada
Fu R, Sutradhar R, Li Q, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Dare A, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Finelli A, Louie AV, Look Hong NJ, Witterick IJ, Mahar A, Urbach DR, McIsaac DI, Enepekides D, Tinmouth J, Eskander A. JAMA Netw Open. 2023; 6(1):e2250394. Epub 2023 Jan 10.